Taki Chemical Co., Ltd.

As of June 30, 2026, Taki Chemical Co., Ltd. carries a market capitalization of 38.98B, placing it among publicly traded companies globally. Its enterprise value stands at 32.35B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Taki Chemical Co., Ltd.'s next confirmed earnings release is scheduled for November 9, 2026.

As of June 30, 2026, Taki Chemical Co., Ltd. has 8.35M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Taki Chemical Co., Ltd. maintains a current ratio of 2.88, meaning it holds 2.9x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Taki Chemical Co., Ltd.'s stock has gained approximately 45.48% over the past 52 weeks. The 50-day moving average sits at 5,822.80, while the 200-day moving average is 4,846.28.

As of June 30, 2026, Taki Chemical Co., Ltd. holds 8.27B in cash and equivalents against 1.19B in total debt, resulting in a net debt position of -7.28B. Total book value stands at 47.04B, with working capital of 20.19B providing operational flexibility.

Taki Chemical Co., Ltd.'s most recent stock split took place on December 26, 2018 with a 1:2 split ratio.